PUMA BIOTECHNOLOGY, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Puma Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Puma Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.42M, a 36.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.42M -$3.12M -36.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $6.23M -$3.68M -37.1% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $7.02M -$3.63M -34.1% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $7.79M -$3.57M -31.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $8.54M -$3.51M -29.1% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $9.91M -$2.81M -22.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $10.7M -$2.72M -20.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $11.4M -$2.66M -18.9% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $12.1M -$2.59M -17.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $12.7M -$2.52M -16.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $13.4M -$2.46M -15.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $14M -$2.39M -14.6% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $14.6M -$2.32M -13.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $15.2M -$2.25M -12.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $15.8M -$2.18M -12.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $16.4M -$2.12M -11.4% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $17M -$3.24M -16% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $17.5M -$3.16M -15.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $18M -$3.1M -14.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $18.5M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $20.2M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $20.7M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $21.1M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.